The Recombinant Methanococcus maripaludis Protein pelota homolog (PelA) is a protein that is produced in yeast . PelA, also known as translation factor pelota, is found in the archaeon Methanococcus maripaludis C6 . M. maripaludis is a fast-growing methanogen that shows promise for the biotechnological conversion of carbon dioxide and renewable hydrogen into fuels and other valuable products .
PelA may function by recognizing stalled ribosomes and interacting with stem-loop structures in stalled mRNA molecules, which effects endonucleolytic cleavage of the mRNA . It may also play a role in the release of non-functional ribosomes and the degradation of damaged mRNAs and possesses endoribonuclease activity . The protein is 348 amino acids long .
Methanococcus maripaludis is a genetically tractable archaeon, making it a suitable host for biotechnological applications and biological studies . Genetic tools, including libraries of promoters, ribosome binding sites (RBS), and neutral sites for chromosomal integration, have been developed to facilitate precise gene expression in M. maripaludis . These tools can improve recombinant protein expression and modulate essential gene expression to generate corresponding physiological changes .
PelA interacts with several predicted functional partners :
ABC transporter related protein (ABX01345.1)
Ribosomal protein L21e (rpl21e)
Ribosomal protein L15e (rpl15e)
Translation elongation factor EF-1, subunit alpha (tuf)
Ribosomal protein S3Ae (rps3ae)
Ribosomal protein S6e (rps6e)
Ribosomal protein L7Ae/L30e/S12e/Gadd45 (rpl30e)
Ribosomal protein L37a (rpl37ae)
30S ribosomal protein S17E (rps17e)
Ribosomal protein L19e (rpl19e)
Global responses of M. maripaludis to specific limitations, such as leucine, phosphate, and H2, have been studied . Leucine limitation resulted in increased mRNA abundance for ribosomal protein genes and increased rRNA abundance . In contrast, phosphate limitation induced a specific response, with a marked increase in mRNA levels for a phosphate transporter .
mRNA levels for the A0A1 ATPase were highest under phosphate limitation, intermediate under H2 limitation, and lowest under leucine limitation conditions . Leucine limitation had the greatest effect, decreasing mRNA levels . Effects on flagellar genes were also complex, with leucine limitation having a negative effect and H2 limitation having a positive effect .
M. maripaludis contains abundant iron-sulfur (Fe-S) proteins that play essential roles . Techniques for anaerobic cultivation of M. maripaludis with formate, liposome-mediated transformation, expression, and anoxic affinity purification of Fe-S proteins have been described .
Recombinant PelA can be produced in yeast with high purity .
| Your Input: | Neighborhood | Gene Fusion | Cooccurrence | Coexpression | Experiments | Databases | Textmining | Homology | Score |
|---|---|---|---|---|---|---|---|---|---|
| pelA | Translation factor pelota; May function in recognizing stalled ribosomes, interact with stem-loop structures in stalled mRNA molecules, and effect endonucleolytic cleavage of the mRNA. May play a role in the release non-functional ribosomes and degradation of damaged mRNAs. Has endoribonuclease activity. (348 aa) | ||||||||
| Predicted Functional Partners: | |||||||||
| ABX01345.1 | ABC transporter related; PFAM: 4Fe-4S ferredoxin iron-sulfur binding domain protein; ABC transporter related; metal-binding domain in RNase L inhibitor, RLI; SMART: AAA ATPase; KEGG: mvn:Mevan_1369 ABC transporter related. | 0.942 | |||||||
| rpl21e | PFAM: Ribosomal protein L21e; KEGG: mvn:Mevan_1105 ribosomal protein L21e; Belongs to the eukaryotic ribosomal protein eL21 family. | 0.937 | |||||||
| rpl15e | PFAM: Ribosomal protein L15e; KEGG: mvn:Mevan_1309 ribosomal protein L15e; Belongs to the eukaryotic ribosomal protein eL15 family. | 0.935 | |||||||
| tuf | Translation elongation factor EF-1, subunit alpha; This protein promotes the GTP-dependent binding of aminoacyl- tRNA to the A-site of ribosomes during protein biosynthesis. Belongs to the TRAFAC class translation factor GTPase superfamily. Classic translation factor GTPase family. EF-Tu/EF-1A subfamily. | 0.927 | |||||||
| rps3ae | PFAM: ribosomal protein S3Ae; KEGG: mvn:Mevan_1522 ribosomal protein S3Ae; Belongs to the eukaryotic ribosomal protein eS1 family. | 0.926 | |||||||
| rps6e | PFAM: Ribosomal protein S6e; KEGG: mvn:Mevan_0522 ribosomal protein S6e; Belongs to the eukaryotic ribosomal protein eS6 family. | 0.912 | |||||||
| rpl30e | PFAM: ribosomal protein L7Ae/L30e/S12e/Gadd45; KEGG: mvn:Mevan_0675 ribosomal protein L7Ae/L30e/S12e/Gadd45; Belongs to the eukaryotic ribosomal protein eL30 family. | 0.911 | |||||||
| rpl37ae | TIGRFAM: ribosomal protein L37a; PFAM: Ribosomal L37ae protein; KEGG: mvn:Mevan_1262 ribosomal protein L37a. | 0.906 | |||||||
| rps17e | KEGG: mvn:Mevan_1450 30S ribosomal protein S17E; Belongs to the eukaryotic ribosomal protein eS17 family. | 0.901 | |||||||
| rpl19e | Ribosomal protein L19e; Binds to the 23S rRNA; Belongs to the eukaryotic ribosomal protein eL19 family. | 0.900 |
| Amino acid | mRNA level (nmol/mg [dry wt]) a |
|---|---|
| Batch culture (± SD) | |
| Thr | 5.03 ± 0.04 |
| Ser | 0.92 ± 0.02 |
| Pro | 4.05 ± 0.05 |
| Gly | 2.40 ± 0.03 |
| Ala | 2.27 ± 0.03 |
| Val | 2.72 ± 0.04 |
| Met | 0.05 ± 0.01 |
| Ile | 0.47 ± 0.00 |
| Leu | 0.44 ± 0.00 |
| Tyr | 0.50 ± 0.00 |
| Phe | 0.48 ± 0.03 |
| Lys | 9.64 ± 0.07 |
| His | 0.60 ± 0.01 |
| Arg | 1.07 ± 0.02 |
| Glu | 223.84 ± 2.77 |
| Asp | 48.76 ± 0.05 |
| Total | 303.23 ± 5.59 |
| Amino acid | mRNA level (nmol/mg [dry wt]) a |
|---|---|
| H 2-limited conditions | |
| Thr | 2.24 |
| Ser | 2.70 |
| Pro | 13.86 |
| Gly | 25.70 |
| Ala | 5.40 |
| Val | 1.23 |
| Met | 0.05 |
| Ile | 1.54 |
| Leu | 1.49 |
| Tyr | 0.73 |
| Phe | 0.60 |
| Lys | 5.71 |
| His | 0.19 |
| Arg | 0.78 |
| Glu | 291.21 |
| Asp | 27.14 |
| Total | 380.58 |
| Amino acid | mRNA level (nmol/mg [dry wt]) a |
|---|---|
| P-limited conditions | |
| Thr | 9.56 |
| Ser | 3.18 |
| Pro | 11.67 |
| Gly | 11.47 |
| Ala | 6.51 |
| Val | 5.29 |
| Met | 0.05 |
| Ile | 5.78 |
| Leu | 3.80 |
| Tyr | 2.20 |
| Phe | 0.74 |
| Lys | 17.62 |
| His | 0.51 |
| Arg | 4.48 |
| Glu | 475.92 |
| Asp | 114.27 |
| Total | 673.04 |
| Amino acid | mRNA level (nmol/mg [dry wt]) a |
|---|---|
| Leu-limited conditions | |
| Thr | 10.75 |
| Ser | 3.55 |
| Pro | 9.63 |
| Gly | 9.07 |
| Ala | 5.14 |
| Val | 15.51 |
| Met | 0.41 |
| Ile | 16.61 |
| Leu | 0.22 |
| Tyr | 3.01 |
| Phe | 1.58 |
| Lys | 12.96 |
| His | 0.41 |
| Arg | 8.89 |
| Glu | 383.99 |
| Asp | 46.62 |
| Total | 528.37 |
Pelota homolog (PelA) may function in recognizing stalled ribosomes, interacting with stem-loop structures in stalled mRNA molecules, and mediating endonucleolytic cleavage of the mRNA. It may play a role in releasing non-functional ribosomes and degrading damaged mRNAs. It exhibits endoribonuclease activity.
KEGG: mmp:MMP0085
STRING: 267377.MMP0085
The pelota homolog (pelA) is an essential protein in Methanococcus maripaludis that functions in mRNA surveillance pathways. It may recognize stalled ribosomes, interact with stem-loop structures in stalled mRNA molecules, and facilitate endonucleolytic cleavage of the mRNA . Additionally, it likely plays a crucial role in releasing non-functional ribosomes and degrading damaged mRNAs, possessing endoribonuclease activity as part of its functional repertoire . Pelota belongs to the eukaryotic release factor 1 family and specifically to the Pelota subfamily, indicating its evolutionary relationship with similar proteins across domains of life . While archaeal pelA functions similarly to its eukaryotic homolog Pelota, there are distinct mechanistic differences that make it valuable for comparative studies of translation quality control systems .
For short-term storage, recombinant pelA protein should be stored at -20°C, while extended storage requires temperatures of -20°C to -80°C to maintain protein stability and activity . Working aliquots can be maintained at 4°C for up to one week, but repeated freezing and thawing should be avoided as this can lead to protein denaturation and loss of activity .
For reconstitution, it is recommended to briefly centrifuge the vial before opening to bring contents to the bottom, then reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL . For long-term storage of reconstituted protein, adding glycerol to a final concentration of 5-50% (with 50% being standard practice) before aliquoting and storing at -20°C/-80°C is recommended . These storage conditions ensure protein stability while maintaining functional integrity for experimental applications.
When designing experiments to assess pelA endoribonuclease activity, researchers should consider the protein's natural interaction with stalled mRNAs and ribosomes. A standard in vitro assay would include:
Buffer composition: Typically a buffer containing 25-50 mM Tris-HCl (pH 7.5-8.0), 50-100 mM KCl, 1-5 mM MgCl₂, and 1 mM DTT provides an optimal environment for pelA activity.
Substrate preparation: Synthetic RNA oligonucleotides containing stem-loop structures similar to those found in stalled mRNAs serve as effective substrates. These should be radiolabeled or fluorescently tagged for detection of cleavage products.
Reaction conditions: Incubation at 30-37°C (reflecting M. maripaludis growth conditions) for 30-60 minutes typically yields measurable cleavage.
Product analysis: The cleavage products can be analyzed by denaturing PAGE followed by autoradiography or fluorescence imaging.
Researchers should include appropriate controls, such as heat-inactivated enzyme, RNase inhibitors, and EDTA treatments, to confirm that observed activity is specifically due to pelA endoribonuclease function. The assay can be modified to investigate the effects of various factors on pelA activity, including temperature, pH, ion concentrations, and potential interacting partners.
The available recombinant pelA proteins from different M. maripaludis strains (C5, C6, C7) show minor sequence variations that may affect experimental outcomes . To address this variability in experimental design:
| Strain | UniProt Accession | Key Sequence Differences | Product Code |
|---|---|---|---|
| C5 | A4G0A4 | V at position 183 | CSB-YP017778MNP |
| C6 | A9A8K6 | M at position 183 | CSB-YP017778MNQ |
| C7 | Not specified | Similar to C6 sequence | Not specified |
When planning experiments, researchers should:
Clearly document which strain's pelA is being used and report the exact sequence.
Consider performing parallel experiments with pelA from different strains to assess whether observed effects are strain-dependent.
When comparing results with published literature, take note of which strain was used in previous studies.
For structure-function studies, amino acid differences at positions like 183 (V vs M) may impact binding characteristics or catalytic activity.
These considerations ensure experimental reproducibility and help resolve potential discrepancies in research findings when working with pelA from different M. maripaludis strains .
To study pelA interactions with ribosomes and mRNA, researchers can employ several complementary approaches:
Co-immunoprecipitation (Co-IP): Using antibodies against tagged pelA to pull down complexes, followed by analysis of associated RNAs and proteins. This can reveal direct interaction partners in the ribosome and mRNA surveillance pathways.
RNA-protein crosslinking: UV or chemical crosslinking methods can capture direct interactions between pelA and RNA substrates. Techniques like CLIP-seq (Crosslinking and Immunoprecipitation followed by sequencing) can identify RNA binding sites with nucleotide resolution.
Surface Plasmon Resonance (SPR) or Bio-Layer Interferometry (BLI): These techniques provide quantitative measurements of binding affinities between pelA and potential RNA substrates or protein partners.
Cryo-EM structural analysis: For high-resolution studies of pelA in complex with stalled ribosomes, cryo-electron microscopy can reveal the structural basis of interactions.
In vivo ribosome profiling: This method can identify mRNAs that accumulate ribosomes in pelA-deficient cells, providing insights into the natural substrates of pelA activity.
When designing these experiments, researchers should consider the archaeal cellular environment, including salt concentrations, pH, and temperature conditions that mimic the natural habitat of M. maripaludis, to ensure physiologically relevant results .
Studying essential genes like pelA presents significant challenges since deletion mutants are not viable. Advanced methodologies to overcome this limitation include:
Conditional expression systems: Implementing tetracycline-responsive or similar inducible promoters to control pelA expression. This allows for controlled depletion of the protein while monitoring phenotypic effects.
Degron tagging: Fusing pelA with a degron tag that allows for rapid, inducible protein degradation without affecting the genomic locus.
Partial function mutations: Creating a library of point mutations that maintain viability but affect specific aspects of pelA function. This requires:
Structure-guided mutation design targeting functional domains
Comprehensive complementation testing
Phenotypic characterization of viable mutants
Trans-complementation approaches: Expressing wild-type pelA from a plasmid while attempting to modify the chromosomal copy.
CRISPR interference (CRISPRi): Using catalytically dead Cas9 to repress but not completely eliminate pelA expression.
These approaches have been successfully applied in archaeal systems, including M. maripaludis, which possesses a well-developed genetic system that allows detailed examination of information processing components . The genome-wide transposon mutagenesis studies conducted in M. maripaludis provide methodological frameworks that can be adapted for targeted studies of essential genes like pelA .
To analyze the domain-specific functions of pelA in mRNA surveillance pathways, researchers can employ several sophisticated approaches:
Structure-guided domain mapping: Using the known sequence and predicted structure of pelA to identify functional domains, such as RNA-binding regions, ribosome interaction surfaces, and catalytic sites. Bioinformatic analysis can predict these domains based on conservation patterns and structural modeling.
Domain swapping experiments: Creating chimeric proteins where domains of pelA are replaced with corresponding domains from homologs (either archaeal or eukaryotic). This can reveal which domains confer specificity for particular functions or substrates.
Site-directed mutagenesis: Systematic mutation of conserved residues within each predicted domain, followed by functional assays to determine:
Effects on RNA binding (using EMSA or filter-binding assays)
Impacts on ribonuclease activity (using in vitro cleavage assays)
Changes in ribosome interaction (using ribosome co-sedimentation)
Alterations in protein-protein interactions (using pull-down assays)
Truncation analysis: Creating a series of N-terminal and C-terminal truncations to determine the minimal functional unit for different activities.
Structural biology approaches: Utilizing X-ray crystallography or cryo-EM to determine the structure of pelA alone and in complex with substrate RNA or ribosomal components.
These approaches can be particularly powerful when combined with the knowledge that pelA functions similarly to eukaryotic Pelota but with distinct mechanisms . The evolutionary relationship between archaeal and eukaryotic mRNA surveillance systems provides a comparative framework for interpreting domain function results.
Investigating the regulatory mechanisms that govern pelA function in archaeal cells requires multifaceted approaches:
Transcriptional regulation analysis:
RNA-seq under various growth conditions to detect changes in pelA expression
Promoter mapping and mutation to identify regulatory elements
ChIP-seq to identify transcription factors that bind the pelA promoter
Post-translational modification (PTM) characterization:
Mass spectrometry to identify potential phosphorylation, methylation, or other modifications
Creation of PTM-mimicking or PTM-deficient mutants to assess functional consequences
Identification of enzymes responsible for PTMs through targeted gene deletion
Protein-protein interaction networks:
Immunoprecipitation coupled with mass spectrometry to identify interacting partners
Yeast two-hybrid or bacterial two-hybrid screens adapted for archaeal proteins
Proximity labeling methods (BioID, APEX) to capture transient interactions
Environmental response profiling:
Measuring pelA activity under different stress conditions (temperature, pH, nutrient limitation)
Assessing changes in pelA localization using fluorescently tagged variants
Quantifying protein abundance changes using targeted proteomics
Ribosome-associated quality control (RQC) pathway mapping:
Genetic screens to identify synthetic interactions with pelA mutations
Epistasis analysis with other RQC components
Global translation profiling using ribosome profiling in pelA-depleted cells
The TRAM0076 RNA chaperone in M. maripaludis, which has been shown to shape the transcriptome , could potentially interact with pelA or affect its function, representing one example of a regulatory mechanism worth investigating in this archaeal system.
The archaeal pelA and eukaryotic Pelota homologs share fundamental functional similarities while exhibiting important mechanistic differences:
Conserved functions:
Mechanistic distinctions:
Eukaryotic Pelota operates in conjunction with a more complex set of factors including Dom34, Hbs1, and ABCE1
Archaeal pelA likely employs simpler interaction networks, though it maintains core functional properties
The eukaryotic system has evolved additional regulatory layers not present in the archaeal counterpart
Evolutionary implications:
The essentiality of pelA in M. maripaludis underscores its fundamental role in archaeal cell viability
The conservation of this system between Archaea and Eukaryotes, but not Bacteria, supports the hypothesis that eukaryotic information processing systems evolved from archaeal ancestors
M. maripaludis, with its genome approximately seven times smaller than S. cerevisiae, provides a simplified model system for studying these evolutionarily conserved mechanisms
This comparative analysis reveals that pelA represents a core component of an ancient quality control system for translation that has been elaborated upon during eukaryotic evolution while maintaining its essential functions. The study of archaeal pelA thus provides unique insights into the fundamental mechanisms of ribosome-associated quality control that preceded the evolution of the more complex eukaryotic systems .
The study of pelA in M. maripaludis offers unique insights into the evolutionary history of mRNA surveillance mechanisms:
Ancestral functions and mechanisms:
pelA represents a simplified version of mRNA surveillance that likely resembles the ancestral form before the divergence of Archaea and Eukaryotes
The essential nature of pelA in Archaea suggests that mRNA quality control was a fundamental cellular process even in the last common ancestor of Archaea and Eukaryotes
Evolutionary trajectory:
Comparing archaeal pelA with eukaryotic Pelota reveals which aspects of mRNA surveillance have been conserved over billions of years and which have evolved more recently
The absence of certain eukaryotic components in the archaeal system highlights the evolutionary innovations that occurred in the eukaryotic lineage
Domain-specific adaptations:
Minor sequence variations between different strains of M. maripaludis (C5, C6, C7) demonstrate ongoing evolutionary refinement within the archaeal domain
Comparison with eukaryotic systems reveals how mRNA surveillance mechanisms have been adapted to accommodate the more complex cellular environments and regulatory requirements of eukaryotes
Horizontal gene transfer assessment:
Analysis of pelA distribution and phylogeny can reveal potential instances of horizontal gene transfer between different archaeal species or across domains
Such analyses can clarify the evolutionary relationships between different versions of mRNA surveillance mechanisms
These evolutionary insights from pelA studies contribute to our understanding of how fundamental cellular processes evolve and adapt while maintaining essential functions. The archaeal system serves as a window into ancient cellular mechanisms that continue to operate in all domains of life, albeit with domain-specific modifications .
The integration of pelA within the broader archaeal information processing system involves multiple interconnected pathways:
Relationship with translation machinery:
pelA interacts directly with ribosomes, particularly those that have stalled during translation
This interaction requires coordination with archaeal translation factors that may differ from their eukaryotic counterparts
The archaeal ribosome structure influences how pelA recognizes and binds to stalled translation complexes
Connection to RNA degradation pathways:
Integration with stress response systems:
pelA function may be regulated in response to cellular stress conditions
Its activity likely coordinates with stress-responsive transcription factors and regulatory proteins
Under certain conditions, pelA activity may be modulated to adjust the stringency of mRNA surveillance
Interaction with archaeal-specific information processing components:
Unlike the Cdc6/Orc system which is absent in Methanococcales, pelA is preserved, suggesting its fundamental importance
pelA likely coordinates with the Mcm7 homolog, which is the only essential Mcm protein in M. maripaludis
The simplified archaeal information processing system provides a clear context for understanding pelA's specific contribution
Potential interaction with RNA chaperones:
Understanding these integrations provides insights into how fundamental cellular processes are coordinated in the archaeal domain and reveals principles of information processing that may apply across domains of life .
Researchers working with recombinant pelA often encounter several technical challenges during expression and purification:
Protein solubility issues:
Challenge: pelA may form inclusion bodies when overexpressed in heterologous systems
Solution: Optimize expression conditions by lowering temperature (16-18°C), using weaker promoters, or adding solubility tags (SUMO, MBP, or GST)
Alternative approach: Develop refolding protocols from inclusion bodies using gradual dialysis to remove denaturants
Maintaining enzymatic activity:
Challenge: Recombinant pelA may lose endoribonuclease activity during purification
Solution: Include reducing agents (DTT or β-mercaptoethanol) in all buffers to protect cysteine residues
Quality control: Implement activity assays at each purification step to track activity retention
Protein stability concerns:
Expression system selection:
Challenge: Choosing between bacterial, yeast, or archaeal expression systems
Consideration: While commercial preparations use yeast expression systems , E. coli systems may require codon optimization
Advanced approach: Consider archaeal expression systems for native-like post-translational modifications
Purification strategy optimization:
By addressing these challenges systematically, researchers can improve the yield and quality of recombinant pelA preparations for downstream functional studies.
When encountering inconsistent results in pelA functional assays, researchers should systematically address potential sources of variability:
Protein quality assessment:
Verify protein integrity before each experiment using SDS-PAGE
Confirm activity using standardized control assays
Consider using analytical techniques like circular dichroism to verify proper folding
Substrate preparation standardization:
Ensure RNA substrates are consistently prepared with verified purity
Check for RNA degradation before each experiment
Consider batch preparation and aliquoting of substrates to minimize variation
Buffer and reaction condition optimization:
Document exact buffer composition and preparation methods
Monitor and control temperature precisely during reactions
Test the effects of different metal ion concentrations on activity
Strain-specific variations:
Experimental controls and normalization:
Include positive and negative controls in every experiment
Develop internal standards for normalization between experiments
Use statistical methods appropriate for the specific assay to determine significance
Equipment and measurement standardization:
Calibrate instruments regularly
Standardize data collection and analysis procedures
Consider blind analysis to reduce experimenter bias
By implementing these troubleshooting approaches, researchers can significantly improve the reproducibility and reliability of pelA functional assays, leading to more consistent and trustworthy experimental results.
When designing comparative experiments between archaeal pelA and eukaryotic Pelota homologs, researchers should consider several critical factors:
Protein preparation consistency:
Use comparable expression and purification methods for both proteins
Verify that both proteins are properly folded using structural characterization methods
Normalize protein concentrations and activity units for direct comparisons
Reaction condition optimization:
Develop buffer systems that support activity of both proteins
Consider the native environmental conditions of each organism (temperature, pH, salt concentration)
Test activity across a range of conditions to identify optimal comparative parameters
Substrate selection and design:
Create RNA substrates that can be recognized by both proteins
Include natural substrates from both archaeal and eukaryotic systems
Design chimeric substrates to test domain-specific recognition
Functional equivalence testing:
Develop complementation assays in both archaeal and eukaryotic systems
Test whether archaeal pelA can rescue phenotypes in eukaryotic Pelota mutants and vice versa
Quantify the degree of functional rescue to assess conservation of activity
Interaction partner considerations:
Identify known binding partners for both proteins
Test cross-reactivity with heterologous binding partners
Assess how interaction networks differ between archaeal and eukaryotic systems
Evolutionary context interpretation:
Consider the evolutionary distance between the species being compared
Interpret differences in light of domain-specific adaptations
Use phylogenetic analysis to contextualize functional differences
Structural comparison approaches:
Obtain high-resolution structures of both proteins when possible
Use structural alignment to identify conserved and divergent regions
Correlate structural differences with functional variations
These considerations help ensure that comparative experiments yield meaningful insights into the conservation and divergence of pelA function across domains of life, contributing to our understanding of the evolution of mRNA surveillance mechanisms .